Bavarian Nordic secures BARDA contract for smallpox vaccine

Tyler Patchen

News Reporter

It seems that smallpox vaccination production is weighing on the mind of the US government. And manufacturer Bavarian Nordic is the latest company to benefit …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bavarian Nordic secures BARDA contract for smallpox vaccine

Tyler Patchen

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

UK’s price watchdog says Lilly’s Alzheimer’s drug is too costly for broad uptake

Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won't need confirmatory study

Amgen preps to launch Eylea biosimilar years early after Regeneron loses appeal

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Bavar­i­an Nordic se­cures BAR­DA con­tract for small­pox vac­cine

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Bavarian Nordic secures BARDA contract for smallpox vaccine